Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:condition |
solid tumors
|
| gptkbp:intervention |
SENTI-301 cell therapy
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:period |
Phase 1
|
| gptkbp:sponsor |
gptkb:Senti_Biosciences
|
| gptkbp:startDate |
2023
|
| gptkbp:status |
recruiting
|
| gptkbp:bfsParent |
gptkb:Senti_Biosciences
gptkb:Senti_Biosciences,_Inc. |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
SENTI-301
|